Physician profile
Ali Syed
NPI 1023436037
$638.26
in general payments reported to CMS, 2019-2025
10 companies · $130 in 2025
The $130 reported for 2025 was less than what a typical Gastroenterology (Internal Medicine) provider received nationally (typical 2025 total: $636).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $279 · 2020: $16.24 · 2021: $143 · 2022: $23.72 · 2023: $47.26 · 2025: $130.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $177.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $176.89 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Abbvie INC. | $219.88 | 2019 | |
| Boston Scientific Corporation | $210.98 | 2019-2023 | Spaceoar Vue System - 10ml |
| Axsome Therapeutics, INC. | $53.90 | 2025 | Symbravo |
| Merz North America, INC. | $40.31 | 2025 | |
| Pfizer INC. | $23.72 | 2022 | |
| Teleflex LLC | $20.28 | 2023 | Vascband |
| Janssen Pharmaceuticals, INC | $18.86 | 2025 | Invega Sustenna |
| Bard Peripheral Vascular, INC. | $17.53 | 2021 | |
| Ferring Pharmaceuticals INC. | $16.56 | 2025 | Adstiladrin |
| Astrazeneca Pharmaceuticals LP | $16.24 | 2020 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Ali Syed listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.